Compass Therapeutics News

Compass Therapeutics | EFFECT: Others

Sep 9 06:06 ET

Compass Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Aug 30 17:28 ET

Compass Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Anderman Jonathan

Aug 14 08:54 ET

Compass Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12 08:05 ET

Compass Therapeutics | 8-K: Compass Therapeutics Reports 2024 Second Quarter Financial Results and Provides Corporate Update

Aug 12 08:05 ET

Compass Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Anderman Jonathan

Aug 9 16:08 ET

Compass Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Blackstone Inc.(6.9%),Blackstone Group Management L.L.C.(6.9%), etc.

Aug 2 16:20 ET

Compass Therapeutics | 8-K: Current report

Jun 17 08:35 ET

Compass Therapeutics | DEFA14A: Others

May 29 14:05 ET

Compass Therapeutics | 8-K: Current report

May 28 16:18 ET

Compass Therapeutics | 10-Q: Q1 2024 Earnings Report

May 13 08:04 ET

Compass Therapeutics | 8-K: Compass Therapeutics Reports 2024 First Quarter Financial Results and Provides Corporate Update

May 13 08:04 ET

Compass Therapeutics | ARS: Annual Report to Security Holders

Apr 29 08:07 ET

Compass Therapeutics | DEFA14A: Others

Apr 29 08:03 ET

Compass Therapeutics | DEF 14A: Definitive information statements

Apr 29 08:03 ET

Compass Therapeutics | 8-K: Current report

Apr 25 08:05 ET

Compass Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(13.7%),OrbiMed Capital GP V LLC(11.1%), etc.

Mar 22 17:03 ET

Compass Therapeutics | 10-K: FY2023 Annual Report

Mar 21 09:06 ET

Compass Therapeutics | 8-K: Current report

Mar 21 09:05 ET

Compass Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Boylan James P

Mar 11 10:17 ET